Princess.im not here to bag the stock.
The p2b study will have to be fantastic and not just borderline.
I just can't see a major PHARMA being interested with 93 patients only in the trial.
Iil ,like I said should have consulted with the FDA prior to the 2b.imo.
The sp today shares my sentiment.
Ann: FDA Clearance - MIS416 Investigational New Drug Application, page-10
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $35.64M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $23.48K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 328289 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 77366 | 3 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| ATX (ASX) Chart |